Western Blot: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications.
Immunogen:
The antiserum was produced against synthesized peptide derived from human AASS. AA range:251-300
Storage:
Rabbit
Storage:
-20°C/1 year
Clonality:
Polyclonal
Isotype:
IgG
Concentration:
1 mg/ml
Observed Band:
102kD
GeneID（Human）:
10157
Human Swiss-Prot No:
Q9UDR5
Cellular localization:
Mitochondrion .
Background:
This gene encodes a bifunctional enzyme that catalyzes the first two steps in the mammalian lysine degradation pathway. The N-terminal and the C-terminal portions of this enzyme contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde. Mutations in this gene are associated with familial hyperlysinemia. [provided by RefSeq, Jul 2008],
Western Blot analysis of various cells using AASS Polyclonal Antibody
Western Blot analysis of HeLa cells using AASS Polyclonal Antibody
Western blot analysis of lysates from 293, HUVEC, and HeLa cells, using AASS Antibody. The lane on the right is blocked with the synthesized peptide.
Western blot analysis of the lysates from COLO205 cells using AASS antibody.